Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors (COMBINE-EGFR-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04626635
Recruitment Status : Recruiting
First Posted : November 12, 2020
Last Update Posted : December 22, 2021
Information provided by (Responsible Party):
Regeneron Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 3, 2025
Estimated Study Completion Date : April 3, 2025